Press releases worldwide
The Golden Ticket 2025 supported by Daiichi Sankyo for the BioM incubator MAxL has been awarded to RNhale. This award provides the Martinsried-based start-up the opportunity to advance its research on RNA-based therapies for lung diseases free of charge for […]
Biotechnology conference “BayOConnect” in Munich brings together players from all areas of Bavarian and international biotechnology. With around 350 participants, over 350 partnering meetings, 10 start-up pitches and 16 poster presentations, 27 exhibitors and over 40 sponsors and partners, BioM […]
With 2.5 million euros in total funding, the Bavarian m4 Award supports innovative biomedical research projects. The selected research projects deal with the major widespread diseases Alzheimer’s, cancer and rheumatoid arthritis and provide solutions for RNA therapies. The prize money […]
Record financing of over 910 million euros Slight increase to 540 biopharma companies 18 start-ups and new settlements show strong start-up momentum in Bavaria Employment remains stable at 57,000 in the biopharma sector Oncology remains the most important indication in […]
The Japanese pharmaceutical company Daiichi Sankyo has become a “Golden Ticket” sponsor of the BioM incubator MAxL (Munich Accelerator Life Sciences & Medicine). Through this partnership, Daiichi Sankyo specifically supports emerging biotech start-ups thereby making an important contribution to promoting […]
Familial risk of cardiac death: 28,000 children and adolescents screened in VRONI study. 250 cases with a genetic increase in risk of early heart attack identified and now undergoing treatment HerzFit app: 150,000 users use DigiMed Bayern tool for their […]
Biotechnology conference "BayOConnect" in Munich unites players from all areas of Bavarian and international biotechnology. With around 320 participants, 250 partnering meetings, 15 start-up pitches, 20 exhibitors and over 30 sponsors and partners, BioM successfully promotes networking in the industry. […]
Employment grows by 14% to 58,000 employees in the Bavarian biopharma sector Slight increase in the numbers of biopharma companies 11 start-ups and two relocations show start-up momentum Record financing of more than 470 million euros Oncology remains the […]
New innovative therapies and diagnostics will be developed in the future at the 900 m2 MAxL – by young start-up teams. MAxL provides founders state-of-the-art laboratory equipment, co-working, meeting and event spaces as well as numerous training and networking opportunities. […]
Eight pre-selected start-ups from medicine and life sciences pitched their business ideas at the 13th BioAngels Pitch Day hosted by BioM, the network organization of the Bavarian biotechnology. In just 12 minutes, founders presented scientific data and corporate strategy to […]